Monument Therapeutics

Monument Therapeutics started as a research project within Cambridge Cognition to develop a better way to stratify patients based on measurable brain function rather than broad diagnoses and, therefore, create more homogeneous patient groups that would respond predictably to specific treatments.

Monument Therapeutics has raised €1.0M across 1 funding round from 4 investors, most recently a round in Feb 2025. Based in Cambridge, UK; active in Healthtech. Data as of 11 Aug 2026.